These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Start hesitation--a side effect of long-term levodopa therapy. Ambani LM; Van Woert MH N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941 [No Abstract] [Full Text] [Related]
25. Long-term treatment of Parkinsonism with L-dopa. Presthus J; Holmsen R Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340 [No Abstract] [Full Text] [Related]
26. [Study of L-dopa treatment and its principal side effects in aged subjects]. Antonini F; Baroni A; Bucalossi A; Roveyaz L Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357 [No Abstract] [Full Text] [Related]
27. [Treatment of parkinsonism with the drug L-DOPA]. Stoliarova LG; Kistenev BA Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170 [No Abstract] [Full Text] [Related]
28. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area. Mars H; Libman I; Schwartz AM; Gillo-Joffroy L; Barbeau A Can Psychiatr Assoc J; 1972 Apr; 17(2):123-31. PubMed ID: 5036506 [No Abstract] [Full Text] [Related]
29. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism]. Gerstenbrand F; Grünberger J; Schubert H Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895 [No Abstract] [Full Text] [Related]
30. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa. Godwin-Austen RB; Bergmann S; Frears CC Br Med J; 1971 Nov; 4(5786):522-4. PubMed ID: 4942463 [TBL] [Abstract][Full Text] [Related]
31. L-Dopa treatment in Parkinson's Disease. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
33. [Long-term treatment of Parkinsonism with L-dopa]. Presthus J; Holmsen R Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916 [No Abstract] [Full Text] [Related]
34. Treatment of Parkinson's disease with L-dopa: a current appraisal. Kofman O Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081 [No Abstract] [Full Text] [Related]
36. A second report on Levodopa. Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281 [No Abstract] [Full Text] [Related]
37. [L-Dopa therapy in Parkinson's disease. A double-blind study]. Worm-Petersen J; Dupont E; Mikkelsen B Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651 [No Abstract] [Full Text] [Related]
38. [Side effects occurring in the course of treatment of parkinsonism with L-dopa]. Kuran W Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001 [No Abstract] [Full Text] [Related]